Why Former Novartis CEO Joe Jimenez Joined A Microbiome Startup’s Board – Forbes
ForbesuBiome, a San Francisco startup that sells commercial tests that use DNA sequencing to identify what microbes are in a person’s stool or, for one test, in the vagina, has raised $83 million from venture capitalists to fund an entrée into drug development.Microbiome Startup uBiome Expands into Drug Research with $83MXconomyA startup that’s helping us […]
from WordPress https://ift.tt/2DjZTMB
via IFTTT
from WordPress https://ift.tt/2DjZTMB
via IFTTT
Post A Comment
No comments :